DFO
MRNA icon

Duquesne Family Office’s Moderna MRNA Stock Holding History

Duquesne Family Office’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22,154
Closed -$3.4M – 62
2023
Q1 		$3.4M Hold
22,154
– – 0.15% 42
2022
Q4 		$3.98M Hold
22,154
– – 0.2% 44
2022
Q3 		$2.62M Sell
22,154
-185,526
-89% -$28.2M 0.15% 56
2022
Q2 		$29.7M Buy
+207,680
New +$29.7M 2.15% 14
2021
Q4 		– Sell
-85,971
Closed -$33.1M – 56
2021
Q3 		$33.1M Sell
85,971
-136,429
-61% -$50.3M 1.07% 19
2021
Q2 		$52.3M Buy
+222,400
New +$39.7M 1.29% 23

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Duquesne Family Office's MRNA Position: Q2 2023 in Review

Duquesne Family Office sold out of Moderna (MRNA) in Q2 2023, closing a stake of 22,154 shares — an estimated $3.4M sold.

Duquesne Family Office first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $52.3M in Q2 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Duquesne Family Office reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Duquesne Family Office sold 22,154 Moderna shares in Q2 2023, an estimated $3.4M.
  • Duquesne Family Office first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Duquesne Family Office's Moderna position peaked at $52.3M in Q2 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Duquesne Family Office's 13F filing for Q2 2023, filed 14 Aug 2023.